approval
saveIMFINZI (DURVALUMAB) — FDA approval
community read0 votes
Sponsor: ASTRAZENECA UK LTD. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 5
- approvalIMFINZI (DURVALUMAB) — FDA approvalAug 15, 2024
- approvalnirsevimab: BEYFORTUS (NIRSEVIMAB-ALIP) — FDA approvalAug 22, 2024
- approvalIMFINZI (DURVALUMAB) — FDA approvalJun 14, 2024
- approvalCALQUENCE: CALQUENCE (ACALABRUTINIB MALEATE) — FDA approvalJun 5, 2024
- approvalCALQUENCE: CALQUENCE (ACALABRUTINIB) — FDA approvalJun 5, 2024
🐶 often sniffed alongside
top 8- tagOncology15 co-mentions · 4 sources
- tagNephrology3 co-mentions · 1 sources
- tagNeurology3 co-mentions · 1 sources
- tagPsychiatry & CNS3 co-mentions · 1 sources
- tagBreast Cancer2 co-mentions · 1 sources
- tagCOPD2 co-mentions · 1 sources
- tagAdCom2 co-mentions · 2 sources
- tagPulmonology2 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that